🇫🇷
France · FR · FR:66610933
XELJANZ 11 mg, comprimé à libération prolongée
ReimbursedATC L04AF01
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerPFIZER EUROPE MA EEIG (BELGIQUE)
CountryFR (France)
ATC codeL04AF01
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip133400930199893plaquette(s) aluminium PVC-Aluminium de 28 comprimésEUR 634.25
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "66610933",
"date_amm": "2019-12-16",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/17/1178",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code L04AF01.
- CAAURO-TOFACITINIBAURO PHARMA INC
- CAAURO-TOFACITINIBAURO PHARMA INC
- CAJAMP TOFACITINIBJAMP PHARMA CORPORATION
- CAPMS-TOFACITINIBPHARMASCIENCE INC
- CATARO-TOFACITINIBTARO PHARMACEUTICALS INC
- CATARO-TOFACITINIBTARO PHARMACEUTICALS INC
- CATARO-TOFACITINIB XRTARO PHARMACEUTICALS INC
- 🇺🇸tofacitinibZydus Lifesciences Limited
Access this data programmatically
Query XELJANZ 11 mg, comprimé à libération prolongée and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.